In This Section

Home / Learn / Publications / Patient Assistance and Reimbursement Guide

Patient Assistance and Reimbursement Guide

Updated October 2020

The 2020 Patient Assistance & Reimbursement Guide has the most up-to-date information on cancer drug assistance and reimbursement programs to help your patients alleviate the financial burden of their treatment.

This guide to financial assistance contains directions on program enrollment from 40 companies, granting eligible insured, underinsured, and uninsured patients access to more than 150 oncology medications at little or no cost, including new programs for Daiichi Sanyko and Epizyme, Inc.

The October 2020 update contains:

  • A Table of Contents listing medications by parenteral or oral administration
  • An updated Quick Reference Guide listing oncology-related medications, companies, and linked assistance websites
  • A message from ACCC Immediate Past President Ali McBride, PharmD, MS, BCOP
  • Top takeaways from the 2019 Financial Advocacy Network Pre-Conference

This PDF updates the print 2020 Patient Assistance & Reimbursement Guide, which was mailed to ACCC members in January 2020.

Email your comments and feedback to Maddelynne Parker, ACCC Content Coordinator.


Also from the patient assistance guide

From the ACCC Financial Advocacy Network

Other Financial Advocacy Resources

Our Financial Advocacy Boot Camp offers a dynamic online curriculum that helps you and your cancer patients navigate the complex healthcare system and pay for their treatment. Learn more about how to be an effective financial advocate.

Learn More

The ACCC Oncology Drug Database contains billing and diagnosis codes, reimbursement amounts, FDA-approved indications, and contact information for every cancer drug on the market.

Access the Database


begin-quoteThe guide is so important to my job and I have helped so many patients as a result. I cannot thank you enough for having this extremely helpful information in one place.

Bonnie Snead
Insurance Authorization Manager
Inova Hematology Oncology
Fairfax, VA end-quote


SITC - Advances in Cancer Immunotherapy